Abstract
The authors tested the association of three vascular endothelial growth factor (VEGF) promoter polymorphisms with sporadic ALS (SALS) to verify the results of a previous study and to investigate their modifier effects on the subphenotypes of SALS in a large family-based and case-control cohort of North American white subjects (N = 1,603). They did not find any association of the VEGF promoter polymorphisms with SALS or its subphenotypes, suggesting that they do not have a direct causal role in ALS.
Original language | English (US) |
---|---|
Pages (from-to) | 508-510 |
Number of pages | 3 |
Journal | Neurology |
Volume | 67 |
Issue number | 3 |
DOIs | |
State | Published - Aug 2006 |
Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology